Alopezien – Diagnostisches und therapeutisches Management

Dr. med. Tobias W. Fischer

Literatur

• 1 Schmidt S, Fischer T W, Chren M M, Strauss B M, Elsner P. Strategies of coping and quality of life in women with alopecia.  Br J Dermatol. 2001;  144 1038-1043
• 2 Fischer T W, Schmidt S, Strauss B, Elsner P. Hairdex – ein Instrument zur Untersuchung der krankheitsbezogenen Lebensqualität bei Patienten mit Haarerkrankungen.  Hautarzt. 2001;  52 219-227
• 3 Hoffmann R, Happle R. Current understanding of androgenetic alopecia. Part I: etiopathogenesis.  Eur J Dermatol. 2000;  10 319-327
• 4 Kaufman K D. Androgen metabolism as it affects hair growth in androgenetic alopecia.  Dermatol Clin. 1996;  14 697-711
• 5 Paus R, Cotsarelis G. The biology of hair follicles.  N Engl J Med. 1999;  341 491-497
• 6 Rebora A. Pathogenesis of androgenetic alopecia.  J Am Acad Dermatol. 2004;  50 777-779
• 7 Trueb R M. Molecular mechanisms of androgenetic alopecia.  Exp Gerontol. 2002;  37 981-990
• 8 Foitzik K, Paus R. Regulation of human hair growth and therapeutic options.  Journal of the German Society of Dermatology. 2005;  3 901-915
• 9 Fischer T W, Paus R. Androgenetic Alopecia. In: Encyclopedia of Molecular Mechanisms of Disease. Berlin; Springer 2006
• 10 Hamilton J B. Patterned loss of hair in man: types and incidence.  Ann N Y Acad Sci. 1951;  53 708-728
• 11 Norwood O T. Male-pattern baldness. Classification and incidence.  South Med J. 1975;  68 1359-1370
• 12 Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.  Br J Dermatol. 1977;  97 247-254
• 13 Wolff H, Kunte C. Diagnostik und Therapie von Haarerkrankungen, Vol. 1. Bremen; Uni-Med 1999
• 14 Bergner T, Braun-Falco O. Die androgenetische Alopezie der Frau.  Hautarzt. 1991;  42 201-210
• 15 Schweikert H U, Wilson J D. Regulation of human hair growth by steroid hormones. I. Testerone metabolism in isolated hairs.  J Clin Endocrinol Metab. 1974;  38 811-819
• 16 Kaufman K D, Olsen E A, Whiting D, Savin R, De Villez R, Bergfeld W, Price V H, Van Neste D, Roberts J L, Hordinsky M, Shapiro J, Binkowitz B, Gormley G J. Finasteride in the treatment of men with androgenetic alopecia. Finasteride male pattern hair loss study group.  J Am Acad Dermatol. 1998;  39 578-589
• 17 Jacobs J P, Szpunar C A, Warner M L. Use of topical minoxidil therapy for androgenetic alopecia in women.  Int J Dermatol. 1993;  32 758-762
• 18 Olsen E A, Dunlap F E, Funicella T, Koperski J A, Swinehart J M, Tschen E H, Trancik R J. A randomized clinical trial of 5 % topical minoxidil versus 2 % topical minoxidil and placebo in the treatment of androgenetic alopecia in men.  J Am Acad Dermatol. 2002;  47 377-385
• 19 Whiting D A, Jacobson C. Treatment of female androgenetic alopecia with minoxidil 2 %.  Int J Dermatol. 1992;  31 800-804
• 20 Lucky A W, Piacquadio D J, Ditre C M, Dunlap F, Kantor I, Pandya A G, Savin R C, Tharp M D. A randomized, placebo-controlled trial of 5 % and 2 % topical minoxidil solutions in the treatment of female pattern hair loss.  J Am Acad Dermatol. 2004;  50 541-553
• 21 Olsen E A, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, Zhang P, Kohut B. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5 % minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.  J Am Acad Dermatol. 2007;  57 767-774
• 22 Freyschmidt-Paul P. Alopecia areata.  CME Dermatologie. 2007;  3 4-14
• 23 Tosti A, Iorizzo M, Botta G L, Milani M. Efficacy and safety of a new clobetasol propionate 0.05 % foam in alopecia areata: a randomized, double-blind placebo-controlled trial.  J Eur Acad Dermatol Venereol. 2006;  20 1243-1247
• 24 Fischer T W. Haarausfall bei internmedizinischen Erkrankungen.  Therapeutische Umschau. 2002;  59 238-242
• 25 Hendrix S, Handjiski B, Peters E M, Paus R. A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice.  J Invest Dermatol. 2005;  125 42-51
• 26 Schell H. Erkrankungen der Haare, Vol. 1. Stuttgart, Berlin, Köln; W. Kohlhammer 1997
• 27 Fischer T, Köhler L D, Vogt H-J. Haarveränderungen durch Krankheit oder Medikamente.  Hautnah Dermatologie. 2000;  5 7-11
• 28 Graham-Little E. Folliculitis decalvans et atrophicans.  Proc Roy Soc Med. 1915;  8 139-140
• 29 Kossard S. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution.  Arch Dermatol. 1994;  130 770-774
• 30 Moreno-Ramirez D, Camacho Martinez F. Frontal fibrosing alopecia: a survey in 16 patients.  J Eur Acad Dermatol Venereol. 2005;  19 700-705
• 31 Kossard S, Lee M S, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris.  J Am Acad Dermatol. 1997;  36 59-66
• 32 Tosti A, Piraccini B M, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women.  J Am Acad Dermatol. 2005;  52 55-60
• 33 Zinkernagel M S, Trueb R M. Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern?.  Arch Dermatol. 2000;  136 205-211
• 34 Wilson C L, Burge S M, Dean D, Dawber R P. Scarring alopecia in discoid lupus erythematosus.  Br J Dermatol. 1992;  126 307-314
• 35 Hermes B, Paus R. „Vernarbende” Alopezien – Anmerkungen zur Klassifikation, Differenzialdiagnose und Pathobiologie.  Hautarzt. 1998;  49 462-472
• 36 Braun-Falco O, Bergner T, Heilgemeir G P. The Brocq pseudopelade – a disease picture or disease entity.  Hautarzt. 1989;  40 77-83
• 37 Paquet P, Pierard G E. Dapsone treatment of folliculitis decalvans.  Ann Dermatol Venereol. 2004;  131 195-197
• 38 Abeck D, Korting H C, Braun-Falco O. Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc.  Acta Derm Venereol. 1992;  72 143-145
• 39 Brooke R C, Griffiths C E. Folliculitis decalvans.  Clin Exp Dermatol. 2001;  26 120-122
• 40 Powell J, Dawber R P. Successful treatment regime for folliculitis decalvans despite uncertainty of all aetiological factors.  Br J Dermatol. 2001;  144 428-429
• 41 Brocq L. Des folliculites et perifolliculites decalvantes.  Bull Mem Soc Med Hop Paris. 1988;  5 399-408
• 42 Price V H, Gummer C L. Loose anagen syndrome.  J Am Acad Dermatol. 1989;  20 249-256
• 43 Hamm H, Traupe H. Loose anagen hair of childhood: The phenomenon of easily pluckable hair.  J Am Acad Dermatol. 1989;  20 242-248
• 44 Tosti A, Peluso A M, Misciali C, Venturo N, Patrizi A, Fanti P A. Loose anagen hair.  Arch Dermatol. 1997;  133 1089-1093
• 45 Antaya R J, Sideridou E, Olsen E A. Short anagen syndrome.  J Am Acad Dermatol. 2005;  53 130-134
• 46 Barraud-Klenovsek M M, Trueb R M. Congenital hypotrichosis due to short anagen.  Br J Dermatol. 2000;  143 612-617
• 47 Van Egmond S, Hoedemaker C, Sinclair R. Short anagen hair naevus: improvement after treatment with 5 % topical minoxidil.  Int J Dermatol. 2007;  46 757-759
• 48 Hoffmann R. TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo.  Eur J Dermatol. 2001;  11 362-368
• 49 Hoffmann R. TrichoScan, a GCP-validated tool to measure hair growth.  J Eur Acad Dermatol Venereol. 2008;  22 132-134; author reply 134 – 135